Facility Flow Is a Quality System
Facility Flow Is a Quality System
A facility can manufacture risk before a batch even starts.
Not because anyone is careless.
Not because people are trying to cut corners.
Because the layout makes bad decisions easier than good ones.
Materials end up where they should not be.
Status gets unclear.
Drug and non-drug work start sharing space without enough control.
People move through the area in ways the procedure never really considered.
Equipment sits where it fits, not where it supports the process.
And suddenly Quality is trying to inspect its way out of a facility design problem.
That rarely ends well.
FDA's July 31 warning letter to FairyGene, Inc. is a useful reminder that layout, flow, segregation, and facility suitability are not background details.
They are quality controls.
The Floor Plan Is Part of the Process
A process is not just the batch record.
It is the room.
The racks.
The staging lanes.
The material labels.
The quarantine area.
The approved area.
The rejected area.
The path people take.
The air that moves through the space.
The surfaces that have to be cleaned.
The places where equipment waits between uses.
FDA stated that FairyGene contract manufactures OTC drug products as well as non-drug products. FDA also cited lack of adequate space and defined areas for equipment and materials to prevent mix-ups and contamination in drug manufacturing.
That is the practical issue.
If the space does not create control, the team has to create control manually every day.
Manual control works until the day pressure, volume, staffing, or habit wins.
Then the facility tells the truth.
Status Control Cannot Be a Guess
Material status should be obvious.
Not theoretically obvious.
Actually obvious.
FDA stated investigators observed materials stored haphazardly on floors, along walls, and in hallways between packaging lines used for drug-product manufacturing. FDA also stated materials lacked clear identification of contents, designated status, intended use, or production-run association.
That is not a paperwork nit.
That is a mix-up risk.
When people cannot quickly tell what a material is, where it belongs, what status it holds, and what batch or run it supports, the system is depending on memory and local knowledge.
Memory is not a control strategy.
Local knowledge is useful.
It is also fragile.
The next shift, new hire, urgent order, or half-labeled bin can break it.
Segregation Has to Be Physical Enough to Work
Segregation sounds simple.
Keep the wrong things apart.
Done.
Except real operations are messy.
Incoming materials arrive before the area is ready.
Rejected material waits for disposition.
Approved material gets staged early because production wants to move.
Non-drug and drug materials both need space.
A hallway becomes temporary storage.
Temporary storage becomes normal storage.
Normal storage becomes how we have always done it.
This is how systems drift.
FDA stated the facility lacked designated areas for quarantining incoming materials and segregating approved from rejected materials.
That matters because status is not just a label.
It is a physical control.
The layout has to help people do the right thing when the day gets busy.
If it only works when everyone is calm, fully staffed, and perfectly attentive, it does not work.
Drug and Non-Drug Work Need Real Boundaries
Manufacturing OTC drug products and non-drug products in the same operation does not automatically mean failure.
But it does raise the burden on control.
The facility has to make boundaries clear.
Materials have to be identified and segregated.
Equipment use has to be controlled.
Cleaning has to be documented and verified.
Personnel and material flow have to reduce mix-up and contamination risk.
Quality has to understand what is happening in the actual space, not just in the procedure.
If those controls are weak, the site is relying on hope and traffic patterns.
Hope is not CGMP.
Traffic patterns are not validation.
Facility Suitability Is Not Cosmetic
FDA also cited concerns about the warehouse environment used for drug manufacturing, including concrete floors, metal sheeting over cinderblock walls, exposed ceiling vents, exposed piping, exposed joists, ceiling fans, and lack of adequate ventilation systems that can create microbial and particulate contamination risks.
This is where some teams get defensive.
The facility is old.
The business is growing.
The space is constrained.
The expansion is planned.
The new warehouse is coming.
All of that may be true.
It does not answer the current quality question.
Can this facility support drug manufacturing today?
Can the surfaces be cleaned and sanitized?
Can airflow and ventilation support the operation?
Can personnel and materials move without creating risk?
Can the infrastructure be remediated, or does the process need to move?
The answer cannot be a future promise dressed as a control.
The Operator Test
If you lead Quality, Operations, Facilities, Validation, or site leadership, walk the facility like the process depends on it.
Because it does.
Start at receiving.
Follow the material.
Where does it go before status is assigned?
Where does quarantine happen?
How does approved material become visibly different from rejected material?
Where is production staging?
Where do non-drug materials cross the drug process?
Where does personnel flow intersect material flow?
Where can airborne, particulate, or microbial risk enter the process?
Which surfaces are difficult to clean?
Which areas only work because one experienced person knows the workaround?
That last one is usually the map to the real problem.
Quality Cannot Own What the Facility Undermines
Quality can review records.
Quality can inspect labels.
Quality can approve procedures.
Quality can raise deviations.
But Quality cannot make a poor layout good by signing harder.
If the facility keeps creating unclear status, storage pressure, uncontrolled flow, or cleanability risk, the quality system will spend its life reacting.
The fix is not more clipboards.
It is control by design.
Defined areas.
Clear status.
Physical segregation.
Cleanable surfaces.
Suitable ventilation.
Material flow that makes sense.
Personnel flow that does not fight the process.
Quality oversight that reaches the floor, not just the file.
That is how a site moves from warehouse improvisation to controlled manufacturing.
The floor plan is not separate from the quality system.
It is part of it.
And it has to be built that way.
Website Publishing Notes
• Stage as Squarespace draft only.
• Set author to Two Pharma Guys.
• Add source URL in the post settings.
• Use the hero image and alt text provided above.
• Do not publish until Micah approves.